Akin Davulcu
About Akin Davulcu
Akin Davulcu is the Head of CMC Development Teams at Bristol Myers Squibb, with extensive experience in the pharmaceutical and agrochemical industries.
Current Role at Bristol Myers Squibb
Akin Davulcu is the Head of CMC Development Teams at Bristol Myers Squibb. He assumed this role in March 2020. In this position, he oversees the development and commercialization of products, ensuring they meet regulatory standards and manufacturing requirements.
Previous Positions at Bristol Myers Squibb
Before his current role, Akin Davulcu served as the Director of CMC Development Teams from 2017 to 2020 in Princeton, NJ, and as Principal Scientist in Process Research and Development from 1999 to 2015 in New Brunswick, NJ. His long tenure at Bristol Myers Squibb showcases his expertise and significant contributions to the company.
Tenure at DuPont
Between his roles at Bristol Myers Squibb, Akin Davulcu worked as a Technical Manager in Process Development at DuPont from 2015 to 2017 in Newark, DE. This position allowed him to expand his knowledge and experience in the agrochemical industry, contributing to his broad understanding of process development.
Educational Background
Akin Davulcu holds a Ph.D. in Organic Chemistry/Complex Molecule Total Synthesis from the University of Pennsylvania, which he earned between 2003 and 2006. He also obtained a BS/MS in Chemistry from The University of Texas at Austin between 1997 and 1999. His solid academic foundation is evident in his professional accomplishments.
Industry Experience and Expertise
Akin Davulcu has extensive experience in both the pharmaceutical and agrochemical industries. His robust background in process research and development, especially in the commercialization of products, underscores his capacity to lead and innovate in his field.